BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 5742339)

  • 1. [Reactogenic activity of C. burneti vaccines. II. Attempts to separate the protecting potency from the toxic and allergenic effects of phase I C. burneti vaccine].
    Crăcea E; Zarnea G; Dumitresco S; Novac S
    Arch Roum Pathol Exp Microbiol; 1968 Sep; 27(3):679-90. PubMed ID: 5742339
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reactogenic activity of C. burneti vaccines. I. Allergenic and toxic properties of phases I and II C. burneti corpuscular vaccines].
    Crăcea E; Zarnea G; Dumitresco S; Novac S
    Arch Roum Pathol Exp Microbiol; 1968 Sep; 27(3):665-78. PubMed ID: 5742338
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunogenic value of various phase I Q vaccines prepared from various strains of Coxiella burneti].
    Zarnea G; Crăcea E; Dumitresco S; Novac S; Mihancea N
    Arch Roum Pathol Exp Microbiol; 1968 Sep; 27(3):691-6. PubMed ID: 5742340
    [No Abstract]   [Full Text] [Related]  

  • 4. Q-fever soluble vaccine effects in Coxiella burneti sensitized humans.
    Crăcea E; Dumitrescu-Constantinescu S; Botez D; Ioanid L
    Zentralbl Bakteriol Orig A; 1977 Jul; 238(3):413-8. PubMed ID: 910580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of a potent vaccine from the attenuated M-44 strain of Coxiella burneti.
    Robinson DM; Hasty SE
    Appl Microbiol; 1974 Apr; 27(4):777-83. PubMed ID: 4825980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precipitation of phase I antigen of Coxiella burnetii by sodium sulfite.
    Wachter RF; Briggs GP; Pedersen CE
    Acta Virol; 1975 Nov; 19(6):500. PubMed ID: 2000
    [No Abstract]   [Full Text] [Related]  

  • 7. The antibody response to antigens of Coxiella burneti.
    Fiset P; Ormsbee RA
    Zentralbl Bakteriol Orig; 1968 Apr; 206(3):321-9. PubMed ID: 5707314
    [No Abstract]   [Full Text] [Related]  

  • 8. [Humoral immune response of goats, rabbits and guinea pigs following vaccination with a Q fever vaccine].
    Schmeer N; Adami M; Döpfer B; Herbst W; Schmuck W
    Berl Munch Tierarztl Wochenschr; 1985 Jan; 98(1):20-4. PubMed ID: 3985935
    [No Abstract]   [Full Text] [Related]  

  • 9. Study of the antigenic structure of Coxiella burneti. VI. Chromatographic analysis of phase I antigen of C. burneti on DEAE-cellulose.
    Brezina R; Schramek S
    Acta Virol; 1968 Jan; 12(1):68-72. PubMed ID: 4384115
    [No Abstract]   [Full Text] [Related]  

  • 10. Guinea pig abscess/hypersensitivity model for study of adverse vaccination reactions induced by use of Q fever vaccines.
    Wilhelmsen CL; Waag DM
    Comp Med; 2000 Aug; 50(4):374-8. PubMed ID: 11020154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phase variations in Coxiella burneti].
    Crăcea E
    Microbiol Parazitol Epidemiol (Bucur); 1967; 12(3):273-81. PubMed ID: 5597258
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of phase variation on the protective activity of C. burneti vaccines.
    Crăcea E; Dumitrescu S; Novac S; Mihancea N
    Arch Roum Pathol Exp Microbiol; 1966 Dec; 25(4):943-50. PubMed ID: 5983323
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the immunogenicity of various phases of the Burneti rickettsia].
    Kudelina RI; Fedorova NI
    Zh Mikrobiol Epidemiol Immunobiol; 1967 May; 44(5):17-21. PubMed ID: 5617968
    [No Abstract]   [Full Text] [Related]  

  • 14. Study of the antigenic structure of Coxiella burneti. VII. Properties of phenol-extracted phase I antigenic component.
    Brezina R; Pospísil V; Schramek S
    Acta Virol; 1970 Jul; 14(4):295-301. PubMed ID: 4394184
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunogenicity and reactogenicity of a Q fever chemovaccine in persons professionally exposed to Q fever in Czechoslovakia.
    Kazár J; Brezina R; Palanová A; Tvrdá B; Schramek S
    Bull World Health Organ; 1982; 60(3):389-94. PubMed ID: 6982774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local pathogenic effects of Q fever vaccines. Some attempts to diminish the local pathogenic effect of phase I Coxiella burneti corpuscular vaccine.
    Crăcea E; Zarnea G; Dumitrescu S; Botez D; Sabin S
    Arch Roum Pathol Exp Microbiol; 1972 Sep; 31(3):367-72. PubMed ID: 4665073
    [No Abstract]   [Full Text] [Related]  

  • 17. [A study of the allergenic properties of the soluble antigen of Rickettsia burneti under experimental conditions].
    Kudelina RI
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Apr; 46(4):95-101. PubMed ID: 5790217
    [No Abstract]   [Full Text] [Related]  

  • 18. Onset and duration of immunity in guinea pigs and mice induced with different Q fever vaccines.
    Kazár J; Votruba D; Propper P; Schramek S
    Acta Virol; 1986 Nov; 30(6):499-506. PubMed ID: 2881470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II to phase I conversion of Coxiella burneti in immunosuppressed mice.
    Kazár J; Brezina R; Skultétyová E; Kovácová E; Schramek S
    Acta Virol; 1975 Jul; 19(4):359-63. PubMed ID: 241236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cellular immune response to antigens of Coxiella burneti.
    Heggers JP; Mallavia LP; Hinrichs DJ
    Can J Microbiol; 1974 May; 20(5):657-62. PubMed ID: 4857620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.